Source: International Congress 2014 – AirPROM: can imaging and modelling take us beyond FEV1?



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vestbo (Hellerup, Denmark). What are the merits of FEV1?. International Congress 2014 – AirPROM: can imaging and modelling take us beyond FEV1?

Member's Comments

No comment yet.

Related content which might interest you: How often FEV1 underestimates bronchodilator response? Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003 Re-assessing the importance of FEV1 decline Source: Eur Respir Monogr 2015; 69: 134-142 Year: 2015 Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma. Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Can the prediction point for FEV1 / FVC be determined in patients with insufficient expiratory maneuver to determine airflow obstruction? Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 What constitutes a rapid fall in serial FEV1? Source: Eur Respir J 2003; 22: Suppl. 45, 118s Year: 2003 Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1 Source: Eur Respir J 2004; 23: 497-498 Year: 2004 Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019 Are 6MWD and FEV1 the most clinically relevant measures? Source: Annual Congress 2012 - Life's a gas: aspects of respiratory gas exchange Year: 2012 Changes in FEV1 over time in COPD and the importance of spirometry reference ranges: the devil is in the detail Source: Breathe, 15 (4) 337; 10.1183/20734735.0252-2019 Year: 2019 The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 FEV6: a shortcut in spirometry? Source: Eur Respir J 2006; 27: 245-247 Year: 2006 When is FEV1 loss excessive? – an investigation of the relationship between year-to-year and long-term spirometry changes Source: Annual Congress 2004 - Longitudinal studies and determinants of lung function and COPD Year: 2004 Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 FEV1/FEV3 ratio: a potential alternative to full spirometry for patients unable to sustain forced expiration? Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Dose omission to shorten methacholine challenge testing: clinical consequences and safety of the use of a "10% fall in FEV1" threshold Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018 IsovolumeFEF25-75%6 and FEV1 for identifying bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 156s Year: 2006 FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007